0000899243-22-039025.txt : 20221219 0000899243-22-039025.hdr.sgml : 20221219 20221219172552 ACCESSION NUMBER: 0000899243-22-039025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221215 FILED AS OF DATE: 20221219 DATE AS OF CHANGE: 20221219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Olagunju Peter CENTRAL INDEX KEY: 0001875057 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38811 FILM NUMBER: 221472140 MAIL ADDRESS: STREET 1: TCR2 THERAPEUTICS INC. STREET 2: 100 BINNEY STREET, SUITE 710 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TCR2 THERAPEUTICS INC. CENTRAL INDEX KEY: 0001750019 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 474152751 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-5200 MAIL ADDRESS: STREET 1: 100 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-15 0 0001750019 TCR2 THERAPEUTICS INC. TCRR 0001875057 Olagunju Peter C/O TCR2 THERAPEUTICS 100 BINNEY STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Technical Officer Common Stock 24092 D Stock Option (Right to Buy) 0.97 2022-12-15 4 A 0 98124 0.00 A 2032-12-14 Common Stock 98124 98124 D Restricted Stock Unit (Right to Buy) 2022-12-15 4 A 0 16354 0.00 A Common Stock 16354 16354 D 25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter. Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration. The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter. /s/ Margaret Siegel as Attorney-in-Fact 2022-12-19